| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.077 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.011 | 0.8 |